Smith & Nephew plc (NYSE:SNN) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of Smith & Nephew plc (NYSE:SNNGet Free Report) have been assigned an average recommendation of “Moderate Buy” from the five research firms that are covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company.

Several equities research analysts have recently weighed in on SNN shares. UBS Group raised shares of Smith & Nephew from a “neutral” rating to a “buy” rating in a research note on Wednesday, June 5th. StockNews.com downgraded shares of Smith & Nephew from a “strong-buy” rating to a “buy” rating in a research note on Monday, May 13th.

Get Our Latest Stock Report on Smith & Nephew

Smith & Nephew Stock Performance

Smith & Nephew stock opened at $25.15 on Wednesday. Smith & Nephew has a 52-week low of $21.52 and a 52-week high of $32.28. The company has a quick ratio of 0.72, a current ratio of 1.77 and a debt-to-equity ratio of 0.44. The firm’s fifty day moving average is $25.01 and its 200 day moving average is $26.33.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the stock. CWM LLC lifted its position in shares of Smith & Nephew by 68.6% during the fourth quarter. CWM LLC now owns 954 shares of the medical equipment provider’s stock worth $26,000 after purchasing an additional 388 shares in the last quarter. Argonautica Private Wealth Management Inc. lifted its position in shares of Smith & Nephew by 4.5% during the fourth quarter. Argonautica Private Wealth Management Inc. now owns 10,362 shares of the medical equipment provider’s stock worth $283,000 after purchasing an additional 449 shares in the last quarter. Highland Capital Management LLC lifted its position in shares of Smith & Nephew by 1.8% during the fourth quarter. Highland Capital Management LLC now owns 24,915 shares of the medical equipment provider’s stock worth $680,000 after purchasing an additional 450 shares in the last quarter. National Bank of Canada FI raised its holdings in Smith & Nephew by 36.0% in the fourth quarter. National Bank of Canada FI now owns 1,967 shares of the medical equipment provider’s stock valued at $53,000 after acquiring an additional 521 shares in the last quarter. Finally, EverSource Wealth Advisors LLC raised its holdings in Smith & Nephew by 75.0% in the fourth quarter. EverSource Wealth Advisors LLC now owns 1,227 shares of the medical equipment provider’s stock valued at $33,000 after acquiring an additional 526 shares in the last quarter. Hedge funds and other institutional investors own 25.64% of the company’s stock.

Smith & Nephew Company Profile

(Get Free Report

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.

Featured Stories

Analyst Recommendations for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.